RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sourav Roy to Pentoxifylline

Back to Details
This is a "connection" page, showing publications Sourav Roy has written about Pentoxifylline.
Sourav Roy
Connection Strength
0.439
Pentoxifylline
  1. Vilar-Pereira G, Casta?o-Barrios LM, Pereira IR, da Silva Pinheiro AP, do Esp?rito Santo Prot?sio da Silva T, Hernandez-Velasco LL, Silva Grij? Farani P, Kulkarni A, Roy S, Mata Dos Santos HA, de Oliveira Lopes R, Tinoco LW, Britto C, Moreira OC, Silva AA, Lannes-Vieira J. Combined benznidazole and pentoxifylline therapy improves behavioral and cognitive changes in association with the regulation of systemic inflammatory profile in chronic experimental Chagas disease. PLoS One. 2025; 20(11):e0334708.
    View in: PubMed
    Score: 0.239
  2. Silva Grij? Farani P, Iandra da Silva Ferreira B, Begum K, Vilar-Pereira G, Pereira IR, Fern?ndez-Figueroa EA, Cardenas-Ovando RA, Almeida IC, Roy S, Lannes-Vieira J, Moreira OC. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy. PLoS Negl Trop Dis. 2023 03; 17(3):e0011223.
    View in: PubMed
    Score: 0.199
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support